Total 48Articles, Present Page 1/5
-
48Korean Pharmacopoeia (Twelfth Edition)Korean Pharmacopoeia (Twelfth Edition) <Notification No.2023-75, Dec 13,2023>
-
01_KP Cover.pdf
-
02_[Appendix 1] General Notices.pdf
-
03_[Appendix 2] General Requirements for Pharmaceutical Preparations.pdf
-
04_[Appendix 3] Monographs_Part1.pdf
-
05_[Appendix 4] Monographs_Part2.pdf
-
06_[Appendix 5] General Tests.pdf
-
07_[Appendix 6] General Information.pdf
2024-01-31 -
-
47Enforcement Rule of the Regulations on Relief of Injury from Side Effects of Drugs(No. 1783)Enforcement Rule of the Regulations on Relief of Injury from Side Effects of Drugs(No. 1783)
-
Enforcement Rule of the Regulations on Relief of Injury from Side Effects of Drugs(No. 1783).pdf
2023-08-29 -
-
46The Enforcement Rule of the Narcotics Control Act (No. 1781)The Enforcement Rule of the Narcotics Control Act (No. 1781)
-
The Enforcement Rule of the Narcotics Control Act (No. 1781).pdf
2023-08-07 -
-
45Regulations on the Criteria for Classification of Drugs(MFDS Notification No.2019-55, July 1, 2019)Regulations on the Criteria for Classification of Drugs(MFDS Notification No.2019-55, July 1, 2019)
-
Regulations on the Criteria for Classification of Drugs (No. 2019-55).pdf
2023-05-31 -
-
44Designation of Drugs Not Eligible for Allowances for Relief of Injury from Adverse Drug Reaction(MFDS Notification, No.2017-62, 25 July 2017)Designation of Drugs Not Eligible for Allowances for Relief of Injury from Adverse Drug Reaction(MFDS Notification, No.2017-62, 25 July 2017)
-
Designation of Drugs Not Eligible for Allowances for Relief of Injury from Adverse Drug Reaction (No.2017-62).pdf
2023-05-31 -
-
43Guideline on Re-Examination Affairs of New Drug,etc.Guideline on Re-Examination of New Drug,etc.(Nov 18, 2021)
-
Guideline on Re-Examination of New Drugs etc. (Nov 18,2021).pdf
2023-03-27 -
-
42Regulation on the Labeling of Medicinal Products,etc.Regulation on the Labeling of Medicinal Products,etc.(No.2020-82, Sep 7, 2020)
-
Regulation on the Labeling of Medicinal Products, etc.(No.2020-82, Sep 7,2020).pdf
2023-03-27 -
-
41Regulation on Good Manufacturing Practices (GMP) for Medicinal ProductsRegulation on Good Manufacturing Practices (GMP) for Medicinal Products.(No.2021-87, Nov 4, 2021)
-
Regulation on Good Manufacturing Practices (GMP) for Medicinal Products (No.2021-87, Nov 4,2021).pdf
2023-03-27 -
-
40Regulation on Fees for Pharmaceutical Approval, etc.Regulation on Fees for Pharmaceutical Approval, etc.(No.2022-46, Jun 27, 2022)
-
Regulation on Fees for Pharmaceutical Approval, etc.(No.2022-46, Jun 27, 2022).pdf
2023-03-27 -
-
39Regulation on Approval for Investigational New Drug Application of Drugs.Regulation on Approval for Investigational New Drug Application of Drugs.(No.2022-81, Nov 23, 2022)
-
Regulation on Approval for Investigational New Drug Application of Drugs(No.2022-81, Nov 23, 2022).pdf
2023-03-27 -